from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3863/-

LFCtreatmentdescriptionclass of inhibitor

0.111

Amikacinug/mL Amikacintranslation

0.491

Cap5-10ug/mL Capreomycintranslation

0.059

Rox10-50 ug/mL Roxithromycintranslation

0.193

SM2-5 ug/mL Streptomycintranslation

-0.266

Tet5-10 ug/mL Tetracyclinetranslation

-0.969

Rif0.2-5ug/mL Rifampicintranscription

-0.668

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.929

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.165

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.840

CPZ10-50 ug/mL Chlorpromazinerespiration

1.047

Clofazimine10-13 ug/mL Clofaziminerespiration

0.144

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.976

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.991

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.913

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.338

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.428

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.086

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.948

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.018

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.719

KCN5-20 ug/mL Potassium cyaniderespiration

0.206

NaN30.2-2 mM Sodium aziderespiration

-0.109

Nigericin50 uM Nigericinrespiration

1.181

TRC10-150 ug/mL Triclosanrespiration

1.205

TRZ10-25 ug/mL Thioridazinerespiration

1.030

Valinomycin0.5-10 uM Valinomycinrespiration

1.091

ZnSO42 mM ZnSO4respiration

0.098

menadione6-10 ug/mL Menadionerespiration

0.197

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.343

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.469

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.273

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.675

NRP_1Non-replicating persistence stage 1dosRassociated

0.262

Amp0.2mg/mL AmpicillincellWall

-0.243

Cephalexin20-100 ug/mL CephalexincellWall

-0.367

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.646

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.826

EMB10-20 ug/mL EthambutolcellWall

-0.547

Eta12-40 ug/mL EthionamidecellWall

-0.509

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.261

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.313

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.171

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.173

BZA0.12 mg/mL BenzamidearomaticAmides

-0.592

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.856

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.083

H2O24 mM hydrogen peroxideDNAdamaging

-0.270

Levo10 ug/mL LevofloxacinDNAdamaging

-0.973

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.899

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.087

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.749

UVUV-irradiationDNAdamaging

0.885

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.119

Antimycin12.5-50 ug/mL Antimycin A?

-0.261

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.331

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.516

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.415

PA8240.2-2 ug/mL PA-824?

-0.641

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.617

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.448

Verapamil50 uM Verapamil?

-0.078

mercaptoethanol2 mM 2-Mercaptoethanol?

0.440

methoxatin10-20 ug/mL Methoxatin?